Brazil Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Region:Central and South America
Product Code:GDMEMC0254DB
August 2017
107
About the Report
Brazil Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary
GlobalData's new report, "Brazil Drug Delivery Devices Market Outlook to 2023", provides key market data on the Brazil Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the Brazil Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Scope of the Report
Products
Companies
B. Braun Melsungen AG
GlaxoSmithKline Plc
Boehringer Ingelheim GmbH
Teleflex Inc
Baxter International Inc
Fresenius Kabi AG
Hospira Inc
AstraZeneca Plc
Smiths Medical
Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A
Medtronic Plc
Terumo Corp
Merck & Co Inc
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Drug Delivery Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Drug Delivery Devices Market, Brazil 10
3.1 Drug Delivery Devices Market, Brazil, Revenue ($m), 2009-2023 10
3.2 Drug Delivery Devices Market, Brazil, Revenue Mix ($m), 2016 12
3.3 Drug Delivery Devices Market, Brazil, Category Contribution by Revenue ($m), 2016 13
3.4 Drug Delivery Devices Market, Brazil, Category Comparison by Revenue ($m), 2009-2023 14
3.5 Drug Delivery Devices Market, Brazil, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, Brazil, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, Brazil, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, Brazil, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, Brazil, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, Brazil, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, Brazil 28
4.1 Central Venous Catheters Market, Brazil, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, Brazil, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, Brazil, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, Brazil, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, Brazil, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, Brazil, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, Brazil, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, Brazil, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, Brazil 41
5.1 Infusion Systems Market, Brazil, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, Brazil, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, Brazil, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, Brazil, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, Brazil, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, Brazil, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, Brazil, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, Brazil, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, Brazil, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, Brazil, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, Brazil, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, Brazil, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, Brazil, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, Brazil, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, Brazil, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, Brazil, Company Share by Revenue ($m), 2016 68
6 Metered Dose Inhaler Devices Market, Russia 70
6.1 Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), 2009-2016 70
6.2 Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), 2016-2023 71
6.3 Metered Dose Inhaler Devices Market, Brazil, Volume (Units), 2009-2016 72
6.4 Metered Dose Inhaler Devices Market, Brazil, Volume (Units), 2016-2023 73
6.5 Metered Dose Inhaler Devices Market, Brazil, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Metered Dose Inhaler Devices Market, Brazil, Company Share by Revenue ($m), 2016 75
7 Needle Free Injections Devices Market, Russia 77
7.1 Needle Free Injections Market, Brazil, Revenue ($m), 2009-2016 77
7.2 Needle Free Injections Market, Brazil, Revenue ($m), 2016-2023 78
7.3 Needle Free Injections Market, Brazil, Volume (Units), 2009-2016 79
7.4 Needle Free Injections Market, Brazil, Volume (Units), 2016-2023 80
7.5 Needle Free Injections Market, Brazil, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Needle Free Injections Market, Brazil, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in Brazil, Drug Delivery Devices Market 84
8.1 B. Braun Melsungen AG 84
8.1.1 Company Overview 84
8.2 GlaxoSmithKline Plc 84
8.2.1 Company Overview 84
8.3 Boehringer Ingelheim GmbH 84
8.3.1 Company Overview 84
8.4 Teleflex Inc 84
8.4.1 Company Overview 84
8.5 Baxter International Inc 85
8.5.1 Company Overview 85
8.6 Fresenius Kabi AG 85
8.6.1 Company Overview 85
8.7 Hospira Inc 85
8.7.1 Company Overview 85
8.8 AstraZeneca Plc 85
8.8.1 Company Overview 85
8.9 Smiths Medical 86
8.9.1 Company Overview 86
8.10 Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A 86
8.10.1 Company Overview 86
8.11 Medtronic Plc 86
8.11.1 Company Overview 86
8.12 Terumo Corp 86
8.12.1 Company Overview 86
8.13 Merck & Co Inc 87
8.13.1 Company Overview 87
9 Drug Delivery Devices Market Pipeline Products 88
10 Financial Deals Landscape 94
10.1 Asset Transactions 94
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
10.2 Partnerships 96
10.2.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 96
10.2.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 97
10.2.3 Pfizer Terminates its Licensing Agreement with pSivida 99
10.2.4 Bayer Enters into Licensing Agreement with DelSiTech 100
10.2.5 BioCorRx Enters into Licensing Agreement with Therakine 101
11 Recent Developments 102
11.1 Product News 102
11.1.1 May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil 102
12 Appendix 103
12.1 Research Methodology 104
12.1.1 Coverage 104
12.1.2 Secondary Research 104
12.1.3 Primary Research 105
12.1.4 Company Share Analysis 105
12.1.5 Distribution Share Analysis 105
12.1.6 Benchmarking 106
12.2 GlobalData Consulting 106
12.3 Contact Us 107
12.4 Disclaimer 107
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.